Abstract

Summary

Six hours of low-intensity blue light (150 lux, 470–490 nm peak) applied daily for 14 days to aged rats improved circadian robustness, increased rest-phase consolidation, and elevated BMAL1-positive cell counts in the SCN, suggesting blue light therapy can partially restore age-related circadian dysfunction. These findings support the potential use of targeted blue-spectrum lighting in elder care environments to strengthen circadian entrainment and reduce rest-activity fragmentation.
Abstract

Key Findings

  • 14 days of 150 lux blue light (470–490 nm, 6 h/day) increased circadian function index and rhythmic robustness in 16-month-old male Wistar rats
  • Blue light exposure increased the number of BMAL1-immunoreactive cells in the SCN, indicating enhanced molecular clock activity
  • Greater consolidation of the resting phase was observed following blue light therapy compared to baseline conditions
  • Sample: 43 male Wistar rats aged 16 months (650–690 g); animals returned to standard light conditions for 14 days post-therapy and effects were assessed at ZT6 and ZT12
Categories

Categories

Sleep & Circadian Health: Evaluates blue light therapy's effect on rest-activity rhythm fragmentation and circadian robustness in aged rats.
Dementia & Elder Care: Addresses age-related circadian dysregulation and SCN deterioration relevant to elder care lighting interventions.
The Science of Light: Investigates neurobiological mechanisms of 470–490 nm blue light on SCN neurochemistry (BMAL1) and neuronal integrity (NeuN).
Authors

Author(s)

EHA Silva
Publication Date

Publication Year

2023
View more publications